We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

PURITAN MEDICAL

Puritan Medical Products is a manufacturer of healthcare, diagnostic and critical environment products. Its portfolio... read more Featured Products: More products

Download Mobile App





Puritan Medical Opening New Facility to Double COVID-19 Swab Production

By LabMedica International staff writers
Posted on 10 Jun 2020
Puritan Medical Products (Guilford, ME, USA) is opening a new facility that will allow the company to produce an additional 20 to 40 million swabs per month in order to fulfill the need for COVID-19 testing swabs in the US.

Puritan is a manufacturer of single-use products for controlled environments, diagnostics and specimen collection, environmental, forensics, and genetics, medical and microbiology media industries. More...
As a FDA-registered and ISO-certified company, Puritan manufactures products, including patented flock swabs, that help customers collect, analyze and transport specimens.

Puritan’s new production facility will be located in the company’s 95,000 square foot building in Pittsfield, ME. The new top-of-the-line medical device manufacturing space will include a Class 7 cleanroom where the swabs will be made. Puritan and its subcontractors are working around the clock to complete the new facility, and the company expects to begin producing swabs at its second plant by July 1, 2020.

“We are committed to providing products and resources to help in this critical effort to stop the spread of COVID-19. Together with our construction and manufacturing partners and our dedicated employees, we are ready and able to increase production to meet our national public health needs,” said Timothy Templet, Executive Vice President of Global Sales for Puritan Medical Products.


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.